DANIELS RONALD J 4
4 · BridgeBio Pharma, Inc. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
DANIELS RONALD J
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-11-06−61,031→ 30,523 totalExercise: $34.65Exp: 2030-02-11→ Common Stock (61,031 underlying) - Sale
Common Stock
2025-11-06$63.72/sh−61,031$3,888,999→ 16,991 total - Exercise/Conversion
Common Stock
2025-11-06$34.65/sh+61,031$2,114,724→ 78,022 total
Footnotes (2)
- [F1]Represents the weighted average sale price of the shares sold from $63.70 to $63.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F2]The shares subject to this option vested and became exercisable in three annual installments from February 12, 2020 to February 12, 2023.